Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 IZDs (mm) of the PGF against different MRSA strains

From: Characterization of the anti-Staphylococcus aureus fraction from Penthorum chinense Pursh stems

Clinical Strains Resistant (R) Susceptible (S) Intermediate (I) IZDs
MRSA 170925062 CLI, CIP, CN, LEV, OX, PEN, SXT, TE, E, MXF F, VAN, LZD, QD, TGC RD 9.0 ± 0.35
MRSA 925059 OX, PEN CLI, CIP, CN, TE, F, LEV, RD, SXT, VAN, E, MXF, LZD, QD, TGC 9.1 ± 0.43
MRSA 920057–1 CLI, CIP, CN, LEV, OX, PEN, SXT, TE, E, MXF F, VAN, LZD, QD, TGC RD 9.0 ± 0.74
MRSA 912036–2 CLI, CIP, CN, LEV, OX, PEN, SXT, TE, E, MXF F, VAN, LZD, QD, TGC RD 8.1 ± 0.43
MRSA 912037 CLI, CIP, CN, LEV, OX, PEN, SXT, TE, E, MXF F, VAN, LZD, QD, TGC RD 11.2 ± 0.76
MRSA 1223064–1 CLI, CIP, LEV, OX, PEN, SXT, TE, E, MXF F, CN, VAN, LZD, QD, TGC RD 10.4 ± 0.43
MRSA 1224057–1 CLI, CIP, LEV, OX, PEN, E, MXF F, CN, VAN, LZD, QD, TGC, TE, RD, SXT 10.1 ± 0.75
  1. Note: “-” indicates that no visible inhibition zone was observed
  2. Abbreviations: CIP Ciprofloxacin, CLI Clindamycin, CN Cephalexin, E Erythromycin, F Nitrofurantoin, LEV Levofloxacin, LZD Linezolid, MXF Moxifloxacin, OX Oxacillin, PEN Penicillin, QD Quinupristin/dalfopristin, RD Rifampicin, SXT Sulfamethoxazole/trimethoprim, 19:1, TE Tetracycline, TGC Tigecycline, VAN Vancomycin